rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2006-6-6
|
pubmed:abstractText |
Asians are generally regarded to tolerate cytotoxic drugs less well than their Caucasian counterpart. A substantial proportion of patients receive suboptimal doses of chemotherapy for fear of severe toxicity. This retrospective study aims to evaluate the adverse events, especially hematological, of docetaxel in Chinese patients with breast cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1340-6868
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
192-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16755116-Adult,
pubmed-meshheading:16755116-Aged,
pubmed-meshheading:16755116-Biopsy, Needle,
pubmed-meshheading:16755116-Breast Neoplasms,
pubmed-meshheading:16755116-Chemotherapy, Adjuvant,
pubmed-meshheading:16755116-China,
pubmed-meshheading:16755116-Dose-Response Relationship, Drug,
pubmed-meshheading:16755116-Drug Administration Schedule,
pubmed-meshheading:16755116-Female,
pubmed-meshheading:16755116-Follow-Up Studies,
pubmed-meshheading:16755116-Hematologic Neoplasms,
pubmed-meshheading:16755116-Humans,
pubmed-meshheading:16755116-Immunohistochemistry,
pubmed-meshheading:16755116-Incidence,
pubmed-meshheading:16755116-Mastectomy, Segmental,
pubmed-meshheading:16755116-Maximum Tolerated Dose,
pubmed-meshheading:16755116-Middle Aged,
pubmed-meshheading:16755116-Neoplasm Invasiveness,
pubmed-meshheading:16755116-Neoplasm Staging,
pubmed-meshheading:16755116-Retrospective Studies,
pubmed-meshheading:16755116-Risk Assessment,
pubmed-meshheading:16755116-Survival Analysis,
pubmed-meshheading:16755116-Taxoids
|
pubmed:year |
2006
|
pubmed:articleTitle |
Clinical experience with docetaxel for Chinese breast cancer patients: hematological toxicity profiles.
|
pubmed:affiliation |
Hung Chao Hong Integrated Centre for Breast Diseases, Department of Surgery, University of Hong Kong Medical Centre, Tung Wah Hospital, Hong Kong, China.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|